161 related articles for article (PubMed ID: 8965348)
21. Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
Lövqvist A; Sundin A; Roberto A; Ahlström H; Carlsson J; Lundqvist H
J Nucl Med; 1997 Jul; 38(7):1029-35. PubMed ID: 9225786
[TBL] [Abstract][Full Text] [Related]
22. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
[TBL] [Abstract][Full Text] [Related]
23. [Potential use of positron-emission tomography in clinical oncology].
Fukuda H; Matsuzawa T; Tateno Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):860-5. PubMed ID: 3291774
[TBL] [Abstract][Full Text] [Related]
24. PET for diagnosis of malignant lymphoma of the scalp: comparison of [11C]methyl-L-methionine and [18F]fluoro-2-deoxyglucose.
Tsuyuguchi N; Hakuba A; Okamura T; Ochi H; Suzuki T; Sunada I
J Comput Assist Tomogr; 1997; 21(4):590-3. PubMed ID: 9216763
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography in oncology: the most sophisticated imaging technology.
Lacić M; Maisey MN; Kusić Z
Acta Med Croatica; 1997; 51(1):1-9. PubMed ID: 9115096
[TBL] [Abstract][Full Text] [Related]
26. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
[TBL] [Abstract][Full Text] [Related]
27. Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET.
Hunter GJ; Choi NC; McLoud TC; Fischman AJ
J Nucl Med; 1993 Sep; 34(9):1571-3. PubMed ID: 8394885
[TBL] [Abstract][Full Text] [Related]
28. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
Wahl RL; Quint LE; Greenough RL; Meyer CR; White RI; Orringer MB
Radiology; 1994 May; 191(2):371-7. PubMed ID: 8153308
[TBL] [Abstract][Full Text] [Related]
29. Lung tumor imaging by positron emission tomography using C-11 L-methionine.
Kubota K; Matsuzawa T; Ito M; Ito K; Fujiwara T; Abe Y; Yoshioka S; Fukuda H; Hatazawa J; Iwata R
J Nucl Med; 1985 Jan; 26(1):37-42. PubMed ID: 2981300
[TBL] [Abstract][Full Text] [Related]
30. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.
Leskinen-Kallio S; Ruotsalainen U; Någren K; Teräs M; Joensuu H
J Nucl Med; 1991 Jun; 32(6):1211-8. PubMed ID: 2045935
[TBL] [Abstract][Full Text] [Related]
31. PET FDG studies in oncology.
Hawkins RA; Hoh CK
Nucl Med Biol; 1994 Jul; 21(5):739-47. PubMed ID: 9241650
[TBL] [Abstract][Full Text] [Related]
32. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Makler PT
J Nucl Med; 1997 Jul; 38(7):1173-4. PubMed ID: 9225819
[No Abstract] [Full Text] [Related]
33. Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma.
Dethy S; Goldman S; Blecic S; Luxen A; Levivier M; Hildebrand J
J Nucl Med; 1994 Jul; 35(7):1162-6. PubMed ID: 8014676
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
Kim EE; Chung SK; Haynie TP; Kim CG; Cho BJ; Podoloff DA; Tilbury RS; Yang DJ; Yung WK; Moser RP
Radiographics; 1992 Mar; 12(2):269-79. PubMed ID: 1561416
[TBL] [Abstract][Full Text] [Related]
35. Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET.
Roelcke U; Radü EW; von Ammon K; Hausmann O; Maguire RP; Leenders KL
J Neurol Sci; 1995 Sep; 132(1):20-7. PubMed ID: 8523026
[TBL] [Abstract][Full Text] [Related]
36. [Comparative analysis of the informative value of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography in the differential diagnosis of solitary lung masses].
Tlostanova MS; Avetisian AO; Kozak AR
Vestn Rentgenol Radiol; 2014; (3):13-9. PubMed ID: 25782293
[TBL] [Abstract][Full Text] [Related]
37. [Cancer screening with whole-body FDG PET].
Yasuda S; Ide M; Takagi S; Shohtsu A
Kaku Igaku; 1996 Oct; 33(10):1065-71. PubMed ID: 8952258
[TBL] [Abstract][Full Text] [Related]
38. Adenocarcinoma of a foregut cyst: detection with positron emission tomography.
Smith SM; Young CS; Bishop AF
AJR Am J Roentgenol; 1996 Nov; 167(5):1153-4. PubMed ID: 8911171
[No Abstract] [Full Text] [Related]
39. PET and [18F]-FDG in oncology: a clinical update.
Conti PS; Lilien DL; Hawley K; Keppler J; Grafton ST; Bading JR
Nucl Med Biol; 1996 Aug; 23(6):717-35. PubMed ID: 8940714
[TBL] [Abstract][Full Text] [Related]
40. Clinical application of PET for the evaluation of brain tumors.
Coleman RE; Hoffman JM; Hanson MW; Sostman HD; Schold SC
J Nucl Med; 1991 Apr; 32(4):616-22. PubMed ID: 2013802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
